Study of an experimental tablet in healthy adults
Part of Digestive system clinical trials.
This study tests an experimental medication called XTYW007 to see if it is safe and how it works in the body. You would take the pills under close supervision and have your health monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old.
- Have a body mass index (BMI) between 18 and 28 (check with your doctor).
- Not have taken any medications, vitamins, or supplements in the past 14 days.
- Avoid grapefruit, mango, dragon fruit, and grape or orange juice for 2 weeks before the trial.
- Not have any serious health issues like heart, liver, kidney, or stomach diseases.
- Be willing to follow strict rules about food, drink, and physical activity during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This trial tests a new pill called QX1206 for people who have both Type 2 diabetes and fatty liver disease (NAFLD). The goal is to see if the medicine is safe and can help improve both conditions.
This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.